Your browser doesn't support javascript.
loading
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
Ragon, Brittany Knick; Shah, Mithun Vinod; D'Souza, Anita; Estrada-Merly, Noel; Gowda, Lohith; George, Gemlyn; de Lima, Marcos; Hashmi, Shahrukh; Kharfan-Dabaja, Mohamed A; Majhail, Navneet S; Banerjee, Rahul; Saad, Ayman; Hildebrandt, Gerhard C; Mian, Hira; Abid, Muhammad Bilal; Battiwalla, Minoo; Lekakis, Lazaros J; Patel, Sagar S; Murthy, Hemant S; Nieto, Yago; Strouse, Christopher; Badawy, Sherif M; Al Hadidi, Samer; Dholaria, Bhagirathbhai; Aljurf, Mahmoud; Vesole, David H; Lee, Cindy H; Pawarode, Attaphol; Gergis, Usama; Miller, Kevin C; Holmberg, Leona A; Afrough, Aimaz; Solh, Melhem; Munshi, Pashna N; Nishihori, Taiga; Anderson, Larry D; Wirk, Baldeep; Kaur, Gurbakhash; Qazilbash, Muzaffar H; Shah, Nina; Kumar, Shaji K; Usmani, Saad Z.
Afiliación
  • Ragon BK; Levine Cancer Institute, Charlotte, NC.
  • Shah MV; Division of Hematology, Mayo Clinic, Rochester, MN.
  • D'Souza A; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Estrada-Merly N; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Gowda L; Yale Cancer Center and Yale School of Medicine, New Haven, CT.
  • George G; University of Colorado School of Medicine, Aurora, CO.
  • de Lima M; The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH.
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Kharfan-Dabaja MA; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.
  • Majhail NS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL.
  • Banerjee R; Sarah Cannon, Nashville, TN.
  • Saad A; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Hildebrandt GC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Mian H; Division of Hematology, The Ohio State University, Columbus, OH.
  • Abid MB; Ellis Fischel Cancer Center, University of Missouri, Columbia, MO.
  • Battiwalla M; McMaster University, Hamilton, ON, Canada.
  • Lekakis LJ; Divisions of Hematology/Oncology & Infectious Diseases, BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI.
  • Patel SS; Sarah Cannon Blood Cancer Network, Nashville, TN.
  • Murthy HS; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL.
  • Nieto Y; Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Strouse C; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL.
  • Badawy SM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Al Hadidi S; Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, IA.
  • Dholaria B; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Aljurf M; Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
  • Vesole DH; University of Arkansas for Medical Sciences, Little Rock, AR.
  • Lee CH; Vanderbilt University Medical Center, Nashville, TN.
  • Pawarode A; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Gergis U; John Theurer Cancer Center at Hackensack Meridian School of Medicine, Hackensack, NJ.
  • Miller KC; Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Holmberg LA; Adult Blood and Marrow Transplantation and Cellular Therapy, Rogel Cancer Center, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI.
  • Afrough A; Department of Medical Oncology, Division of Hematological Malignancies, Thomas Jefferson University, Philadelphia, PA.
  • Solh M; Massachusetts General Hospital, Boston, MA.
  • Munshi PN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Nishihori T; Myeloma, Waldenstrom's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
  • Anderson LD; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA.
  • Wirk B; Stem Cell Transplant and Cellular Immunotherapy Program, MedStar Georgetown University Hospital, Washington, DC.
  • Kaur G; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Qazilbash MH; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL.
  • Shah N; Myeloma, Waldenstrom's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
  • Kumar SK; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA.
  • Usmani SZ; Myeloma, Waldenstrom's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
Blood Adv ; 7(12): 2746-2757, 2023 06 27.
Article en En | MEDLINE | ID: mdl-36827681
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Neoplasias Hematológicas / Mieloma Múltiple Tipo de estudio: Etiology_studies Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Nueva Caledonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Neoplasias Hematológicas / Mieloma Múltiple Tipo de estudio: Etiology_studies Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Nueva Caledonia